Published in Cancer Res on April 01, 1986
Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet (1994) 1.80
Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A (1988) 1.76
Nuclear lamin functions and disease. Trends Genet (2012) 1.52
Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. Am J Pathol (1989) 1.27
Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J Med Genet (1990) 1.21
Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc Natl Acad Sci U S A (1988) 1.14
Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc Natl Acad Sci U S A (1993) 1.14
Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. Am J Pathol (1993) 1.06
The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy. Kidney Int (2009) 1.03
The von Hippel-Lindau gene: turning discovery into therapy. Cancer (2008) 0.97
Familial renal cell carcinoma: clinical and molecular genetic aspects. Br J Cancer (1991) 0.91
Nonhomologous chromatid exchange in hereditary and sporadic renal cell carcinomas. Proc Natl Acad Sci U S A (1991) 0.90
Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint. Proc Natl Acad Sci U S A (1993) 0.84
Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression. J Exp Med (1989) 0.83
Strength of molecular cytogenetic analyses for adjusting the diagnosis of renal cell carcinomas with both clear cells and papillary features: a study of three cases. Virchows Arch (2010) 0.82
Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines. Br J Cancer (1996) 0.79
Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study. Virchows Arch (2009) 0.77
The human loci DNF15S2 and D3S94 have a high degree of sequence similarity to acyl-peptide hydrolase and are located at 3p21.3. Am J Hum Genet (1992) 0.75
International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood (1997) 20.41
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg (1966) 3.06
The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet (1996) 3.05
The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res (1980) 2.97
The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol (1993) 2.95
Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet (1986) 2.78
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet (1996) 2.78
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients. Leukemia (2005) 2.71
Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet (1998) 2.27
Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest (1997) 2.25
The journal "impact factor": a misnamed, misleading, misused measure. Cancer Genet Cytogenet (1998) 2.23
LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum Mol Genet (1999) 2.16
What young men know about testicular cancer. Prev Med (1983) 2.08
Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev (1992) 2.05
Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene (2012) 2.01
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Culture of human leukemia cells. Cancer (1966) 1.94
Disappearance of a structural chromatin protein A24 in mitosis: implications for molecular basis of chromatin condensation. Proc Natl Acad Sci U S A (1979) 1.91
Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia (2002) 1.85
Vasectomy and prostate cancer risk. Am J Epidemiol (1990) 1.84
Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol (1997) 1.83
Characterization of a new primary human pancreatic tumor line. Cancer Invest (1986) 1.67
Structure of rice ferricytochrome c at 2.0 A resolution. J Mol Biol (1983) 1.67
Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer (2001) 1.65
Reversal of X-inactivation in female mouse somatic cells hybridized with murine teratocarcinoma stem cells in vitro. Cell (1983) 1.59
Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol (1991) 1.57
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group. J Clin Oncol (2000) 1.53
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer (1985) 1.51
Myelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: steroid therapy resolved cytopenias and all immune disorders. Intern Med (2001) 1.51
Dissecting aortic aneurysm as a complication of generalized fibromuscular dysplasia. Hum Pathol (1992) 1.51
Diagnosis of chronic liver disease from liver scintiscans by fuzzy reasoning. J Nucl Med (1995) 1.50
Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet (1986) 1.49
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Leukemia (2010) 1.48
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer (1985) 1.48
Secondary tumors of the prostate. J Urol (1985) 1.48
Isopeptidase: a novel eukaryotic enzyme that cleaves isopeptide bonds. Proc Natl Acad Sci U S A (1982) 1.47
Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol (1996) 1.46
The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder. J Urol (1981) 1.44
Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases. J Urol (1995) 1.44
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler (2008) 1.44
A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med (1999) 1.43
High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer (2007) 1.42
Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet (1984) 1.42
Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol (1976) 1.41
A comparison of the W-stapled ileal reservoir with hand-sewn reservoirs for orthotopic bladder replacement. Urology (1996) 1.40
Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia. Leuk Res (2000) 1.39
All-trans-retinoic acid induced enrichment of functionally normal neutrophils in vivo in a patient with acute promyelocytic leukemia. Leukemia (1992) 1.39
Trisomy 14: a new entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1989) 1.39
Involvement of 6p in benign lipomas. A new cytogenetic entity? Cancer Genet Cytogenet (1989) 1.39
The in vitro effects of all-trans-retinoic acid and hematopoietic growth factors on the clonal growth and self-renewal of blast stem cells in acute promyelocytic leukemia. Leuk Res (1997) 1.38
Response of men with advanced prostatic carcinoma to exogenous administration of testosterone. Cancer (1967) 1.38
Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene (2006) 1.37
Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab Invest (1993) 1.35
Recurrent duodenal gangliocytic paraganglioma with lymph node metastases. Histopathology (1993) 1.35
Isolation and characterization of free radical scavenging activities peptides derived from casein. J Nutr Biochem (2000) 1.33
Some urological aspects of 93 consecutive renal homotransplants in modified recipients. J Urol (1967) 1.32
High flow malignant priapism with isolated metastasis to the corpora cavernosa. Urology (1998) 1.31
Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett (1997) 1.29
Hybridization of nuclear matrix attached deoxyribonucleic acid fragments. Biochemistry (1981) 1.26
A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg (1976) 1.26
Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet (1986) 1.26
Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol (1989) 1.26
Proton radiation as boost therapy for localized prostatic carcinoma. JAMA (1979) 1.25
Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol (1982) 1.24
Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res (1994) 1.24
Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer (1992) 1.23
Renal cell carcinoma with inferior vena cava tumor thrombi. Surg Gynecol Obstet (1991) 1.22
Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst (1983) 1.22
Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer (1989) 1.21
Carcinoma of the prostate and lymphatic metastases. J Urol (1974) 1.21
Juvenile muscular atrophy of the distal upper limb (Hirayama disease) associated with atopy. J Neurol Neurosurg Psychiatry (2001) 1.21
Quantitative conservation of chromatin-bound RNA polymerases I and II in mitosis. Implications for chromosome structure. J Cell Biol (1979) 1.20
18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma. Cancer (1997) 1.20
Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci U S A (1987) 1.20
Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet (1986) 1.19
The chromosomes and causation of human cancer and leukemia. Cancer Res (1966) 1.19
Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer (1992) 1.18
Nurse practitioners in primary care. 3. The southern Ontario randomized trial. Can Med Assoc J (1973) 1.18
MEIS1 and HOXA7 genes in human acute myeloid leukemia. Leuk Res (2000) 1.18
Increased sister chromatid exchange in bone marrow and blood cells from Bloom's syndrome. Cytogenet Cell Genet (1976) 1.17
Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors. Clin Cancer Res (2001) 1.17
Studies on the steroid hydroxylation system in adrenal cortex microsomes. Purification and characterization of cytochrome P-450 specific for steroid C-21 hydroxylation. J Biol Chem (1980) 1.17
Induction of prophase in interphase nuclei by fusion with metaphase cells. J Cell Biol (1972) 1.16
Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol (1998) 1.16
The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia (1999) 1.15
Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology (1995) 1.14
New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett (1997) 1.14
Cell cycles in two cell lines of human bladder carcinoma. Tohoku J Exp Med (1977) 1.14
Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Ann Surg (1990) 1.13
Management of primary urethral cancer. Urology (1998) 1.13
Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res (1994) 1.13
The role of surgery in the potentially curative treatment of bladder carcinoma. Cancer Res (1977) 1.13
Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol (1985) 1.12
Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol (1998) 1.12
Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem (1979) 1.12
Three possible cytogenetic subgroups of leiomyosarcoma. Cancer Genet Cytogenet (1989) 1.11